Mpox vaccine maker says 'better prepared' than in 2022

Danish drugmaker Bavarian Nordic said Thursday that it was "better prepared" to supply its mpox vaccine for the current surge of the virus than it was for the 2022 epidemic. Last week, the health agency of the African Union said some 200,000 vaccines would be deployed across Africa, thanks to agreements with the EU and the Danish drugmaker, whose vaccine was approved in 2019.